Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06564636 · ClinicalTrials.gov registry record
A Multi-Centre Study in Patients Undergoing Total Hip Arthroplasty With the Smith+Nephew CATALYSTEM™ Primary Hip System
A clinical trial of Osteoarthritis and Avascular Necrosis, sponsored by Smith & Nephew.
- Active
- Registry status
- 119
- Enrollment target
- 10
- Study locations
NCT06564636: Active study of Osteoarthritis and Avascular Necrosis, sponsored by Smith & Nephew.
NCT06564636 is a study of Osteoarthritis and Avascular Necrosis that is active but no longer recruiting, run by Smith & Nephew. The registered enrollment target is 119 participants, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (85% lower). The trial reports 10 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06564636, a study of Osteoarthritis and Avascular Necrosis, is active but no longer recruiting, sponsored by Smith & Nephew.
- ACTIVE NOT RECRUITING
- Registry status
- 119 participants
- Enrollment target
- 10
- Study locations
Study Summary
A Multi-Center Study in Patients Undergoing Total Hip Arthroplasty with the Smith+Nephew CATALYSTEM™ Primary Hip System. The purpose of the study is to assess safety and performance of the CATALYSTEM™ and to support product approval in global markets.
Primary Outcome
Stem survivorship is defined as no aseptic revision of the implanted femoral stem
Conditions Studied
Interventions
- DEVICE CATALYSTEM
Study Locations (10)
California
- University of California at San Francisco - San Francisco
Connecticut
- Connecticut Orthopaedic Institute - Hamden
Florida
- Orlando Health Inc. - Orlando
Illinois
- Illinois Bone and Joint Institute - Des Plaines
New York
- NYU Langone Health Orthopedic Hospital - New York
North Carolina
- Duke Health - Morrisville
Alberta
- University of Alberta - Edmonton
British Columbia
- University of British Columbia - Vancouver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2024-09-26 |
| Est. Completion | 2036-03 |
What the registry record for NCT06564636 still lists
NCT06564636 is an observational study that tracks outcomes without assigning an intervention. The registered 119 participants enrollment target is mid-sized for trials with a published cap, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (85% lower).
The record links to 7 conditions, with Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which CATALYSTEM is the first listed.
NCT06564636 lists 10 locations in 10 states (California, Connecticut, Florida).
Frequently Asked Questions
What is clinical trial NCT06564636 about?
NCT06564636 is a clinical study titled "A Multi-Centre Study in Patients Undergoing Total Hip Arthroplasty With the Smith+Nephew CATALYSTEM™ Primary Hip System". A Multi-Center Study in Patients Undergoing Total Hip Arthroplasty with the Smith+Nephew CATALYSTEM™ Primary Hip System. The purpose of the study is to assess safety and performance of the CATALYSTEM™ and to support product approval in global markets.
What is the current status of trial NCT06564636?
This trial is currently active not recruiting. The enrollment target is 119 participants. The study started on 2024-09-26. Estimated completion is 2036-03.
What conditions does trial NCT06564636 study?
This clinical trial studies the following conditions: Osteoarthritis, Avascular Necrosis, Post Traumatic Arthritis, Inflammatory Arthritis, Degenerative Joint Disease.
What interventions are being tested in trial NCT06564636?
The interventions under investigation include: CATALYSTEM (DEVICE).
Who is sponsoring clinical trial NCT06564636?
This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06564636 being conducted?
This trial has 10 study locations across California, Connecticut, Florida, Illinois, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06564636's enrollment target sits among peer trials
119 82nd of 135 higher than 54 of 135 other Osteoarthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoarthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Knee
RECRUITING · Phase 2
-
A Prospective, Post-Market, Clinical Follow-up Study of the Incompass™ Total Ankle System
RECRUITING
-
Reliability of Pupil Response to Acute Pain
RECRUITING
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
Ketorolac in Upper Extremity Tendinopathy and Arthropathy
RECRUITING · Phase 4
-
The PROACTIVE Study for Black Elders
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04870762 · 119 participants · Phase 2
Customized 3D Printed Oral Stents During Head and Neck Radiotherapy
- NCT05559853 · 119 participants
Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
- NCT06564389 · 119 participants · Phase 1
FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
- NCT06742801 · 119 participants · NA
Onyx™ Liquid Embolic IDE Clinical Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI